Tanja Kuchenmüller
Datos Biográficos
| ID | 9075233 |
|---|---|
| NOMBRE | Tanja Kuchenmüller |
| NOMBRES | Tanja |
| APELLIDO | Kuchenmüller |
| FIRMA | KUCHENMÜLLER T |
| AFILIACIONES | World Health Organization |
| ORCID | 0000-0002-9021-981X |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 6 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 6 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2021 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Shifting the centre of gravity in the global evidence ecosystem for health
BOX Global challenges in recent years, including humanitarian, climate-related and public health crises, have highlighted critical weaknesses in the application of evidence in decision-making, both locally and globally
Ethical priorities for international collaborative adaptive platform trials for public health emergencies
Rapidly produced evidence on effective medical counter measures is critical for responding to health emergencies caused by (re-)emerging infectious diseases. Adaptive platform trials played a significant role in the global research response to COVID-19 and are likely to be increasingly used in the future, both in emergency and non-emergency contexts. We call attention to a number of ethical considerations that should influence the development and…
Translating health information into policy-making
A comprehensive monitoring and evaluation framework for evidence to policy networks
Time for a new global roadmap for supporting evidence into action
Covid-19
The COVID-19 pandemic has put research evidence and its use in health policy-making under a new spotlight.1 Faced with the need for immediate action, as most recently shown with vaccination roll-out strategies,2 many politicians and other leaders have publicly stressed the need to follow the ‘science’. Scientific advisors and advisory bodies have gained unprecedented visibility. At the same time, the conflicts between researchers/health experts a…
Sin obras prominentes en esta página.
Covid-19
The COVID-19 pandemic has put research evidence and its use in health policy-making under a new spotlight.1 Faced with the need for immediate action, as most recently shown with vaccination roll-out strategies,2 many politicians and other leaders have publicly stressed the need to follow the ‘science’. Scientific advisors and advisory bodies have gained unprecedented visibility. At the same time, the conflicts between researchers/health experts a…
Translating health information into policy-making
A comprehensive monitoring and evaluation framework for evidence to policy networks
Time for a new global roadmap for supporting evidence into action
Ethical priorities for international collaborative adaptive platform trials for public health emergencies
Rapidly produced evidence on effective medical counter measures is critical for responding to health emergencies caused by (re-)emerging infectious diseases. Adaptive platform trials played a significant role in the global research response to COVID-19 and are likely to be increasingly used in the future, both in emergency and non-emergency contexts. We call attention to a number of ethical considerations that should influence the development and…
Shifting the centre of gravity in the global evidence ecosystem for health
BOX Global challenges in recent years, including humanitarian, climate-related and public health crises, have highlighted critical weaknesses in the application of evidence in decision-making, both locally and globally
Political science (5 obras) · Business (3 obras) · Computer Science (3 obras) · Knowledge management (3 obras) · Knowledge translation (3 obras) · Climate Change and Health Impacts (2 obras) · Health Policy Implementation Science (2 obras) · Medicine (2 obras) · Nursing (2 obras) · Process management (2 obras)